Abstract:Innate immunity in the CNS depends primarily on the functions of glial cells, astrocytes and microglia, which are important for the early control of pathogen replication and direct the recruitment and activation of cells of the adaptive immune system required for pathogen clearance. Efficient immune responses are required for clearance of an invading pathogen, but dysregulation of a proinflammatory response in the CNS could lead to the development of autoimmunity. This review summarizes the activation of Toll-… Show more
“…In vitro studies showed that heat inactivated GBS and a secreted factor 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 30 from GBS induced neuronal apoptosis via the TLR2 and MyD88 dependent production of NO from microglia. This observation is indicative of a mode of neurodegeneration that may contribute to the disease process of GBS meningitis in neonates [17]. Furthermore GBS can trigger microglial apoptosis in a pathway dependent upon TLR2 and caspase 8 [101].…”
Section: Tlrs In Response To Bacterial Meningitismentioning
confidence: 88%
“…In contrast human neurons only express TLR3 [14], while Page 7 of 62 A c c e p t e d M a n u s c r i p t 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 7 both mouse and human microglia express mRNA for TLR1-9 [15] [16] (Table 1). The expression of TLR3 is particularly interesting as it is highly expressed in both murine and human astrocytes and highly expressed in the resting CNS [17] suggesting that it may have vital immune or homeostatic roles in the brain.…”
Section: Tlr Expression In Cells Of the Brainmentioning
confidence: 99%
“…For example microglia expressing TLRs are located at regions exposed to the circulation such as the circumventricular organs, meninges and choroid plexus [17,18]. TLR expression in the CNS is enhanced by bacterial and viral infection in order to initiate an inflammatory response [17].…”
Section: Role Of Tlrs In Infectious Diseases Of the Brainmentioning
confidence: 99%
“…For example microglia expressing TLRs are located at regions exposed to the circulation such as the circumventricular organs, meninges and choroid plexus [17,18]. TLR expression in the CNS is enhanced by bacterial and viral infection in order to initiate an inflammatory response [17]. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 26 microglia and astrocytes with either TLR ligands or pathogens results in the production of a variety of inflammatory mediators [17].…”
Section: Role Of Tlrs In Infectious Diseases Of the Brainmentioning
A key part of the innate immune system is a network of pattern recognition receptors (PRRs) and their associated intracellular signalling pathways. Toll-like receptors (TLRs) are one such group of PRRs that detect pathogen associated molecular patterns (PAMPs). Activation of the TLRs with their respective agonists results in the activation of intracellular signalling pathways leading to the expression of proinflammatory mediators and anti-microbial effector molecules. Activation of the innate immune system through TLRs also triggers the adaptive immune response, resulting in a comprehensive immune program to eradicate invading pathogens. It is now known that immune surveillance and inflammatory responses occur in the central nervous system (CNS).
Furthermore it is becoming increasingly clear that TLRs have a role in such CNS responses andare also implicated in the pathogenesis of a number of conditions in the CNS, such as Alzheimer's, stroke and multiple sclerosis. This is likely due to the generation of endogenous TLR agonists in these conditions which amplifies a detrimental neurotoxic inflammatory response. However TLRs in some situations can be neuroprotective, if triggered in a favourable context. This review aims to examine the recent literature on TLRs in the CNS thus demonstrating their importance in a range of infectious and non-infectious diseases of the brain.
“…In vitro studies showed that heat inactivated GBS and a secreted factor 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 30 from GBS induced neuronal apoptosis via the TLR2 and MyD88 dependent production of NO from microglia. This observation is indicative of a mode of neurodegeneration that may contribute to the disease process of GBS meningitis in neonates [17]. Furthermore GBS can trigger microglial apoptosis in a pathway dependent upon TLR2 and caspase 8 [101].…”
Section: Tlrs In Response To Bacterial Meningitismentioning
confidence: 88%
“…In contrast human neurons only express TLR3 [14], while Page 7 of 62 A c c e p t e d M a n u s c r i p t 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 7 both mouse and human microglia express mRNA for TLR1-9 [15] [16] (Table 1). The expression of TLR3 is particularly interesting as it is highly expressed in both murine and human astrocytes and highly expressed in the resting CNS [17] suggesting that it may have vital immune or homeostatic roles in the brain.…”
Section: Tlr Expression In Cells Of the Brainmentioning
confidence: 99%
“…For example microglia expressing TLRs are located at regions exposed to the circulation such as the circumventricular organs, meninges and choroid plexus [17,18]. TLR expression in the CNS is enhanced by bacterial and viral infection in order to initiate an inflammatory response [17].…”
Section: Role Of Tlrs In Infectious Diseases Of the Brainmentioning
confidence: 99%
“…For example microglia expressing TLRs are located at regions exposed to the circulation such as the circumventricular organs, meninges and choroid plexus [17,18]. TLR expression in the CNS is enhanced by bacterial and viral infection in order to initiate an inflammatory response [17]. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 26 microglia and astrocytes with either TLR ligands or pathogens results in the production of a variety of inflammatory mediators [17].…”
Section: Role Of Tlrs In Infectious Diseases Of the Brainmentioning
A key part of the innate immune system is a network of pattern recognition receptors (PRRs) and their associated intracellular signalling pathways. Toll-like receptors (TLRs) are one such group of PRRs that detect pathogen associated molecular patterns (PAMPs). Activation of the TLRs with their respective agonists results in the activation of intracellular signalling pathways leading to the expression of proinflammatory mediators and anti-microbial effector molecules. Activation of the innate immune system through TLRs also triggers the adaptive immune response, resulting in a comprehensive immune program to eradicate invading pathogens. It is now known that immune surveillance and inflammatory responses occur in the central nervous system (CNS).
Furthermore it is becoming increasingly clear that TLRs have a role in such CNS responses andare also implicated in the pathogenesis of a number of conditions in the CNS, such as Alzheimer's, stroke and multiple sclerosis. This is likely due to the generation of endogenous TLR agonists in these conditions which amplifies a detrimental neurotoxic inflammatory response. However TLRs in some situations can be neuroprotective, if triggered in a favourable context. This review aims to examine the recent literature on TLRs in the CNS thus demonstrating their importance in a range of infectious and non-infectious diseases of the brain.
“…Moreover, IL-6 promotes Th17 and B cell differentiation [60], whereas, IFN-γ induced JAK1/2-STAT1 signaling effect which was observed in classically-activated macrophages [61] IL-27 JAK1/STAT-3 Treg IL-10, TGFRβ1 [34] JAK/STAT4 and NF-κB play important role in the pathways involved in pro-inflammatory processes [54]. Activation of the NF-κB transcription factor results in production of proinflammatory cytokines, nitric oxide (NO) and secretion of chemokines by macrophages, whereas on Dendritic cells there is increase expression of CD83, CD86, and CD40, as well as MHC class II [64] which could be important in MS pathogenesis.…”
Section: Jak/stat Pathway and Cytokines In Msmentioning
Multiple sclerosis (MS) is a complex inflammatory and demyelinating disease of central nervous system (CNS). The disease pathogenesis is not fully understood and no actual cure for the disease yet. The disease has genetic and environmental cause as fundamental factors which are identified for the disease pathogenesis so far. One of the characteristic features of the disease is inflammation cause due to activation of pro-inflammatory cells. Interference in signalling pathways such as JAK/STAT could result in physiological or pathological outcome in MS. Dysregulation of JAK/STAT signalling pathway is associated with chronic inflammatory process and immune disorders. In this review, considering the important role of JAK/STAT pathway in signal transduction of inflammatory process and immune responses in CNS, we describe the involvement of this signal transduction pathway in MS. Moreover, we consider the physiological and pathological involvement of JAK/STAT rout in neurogenesis/gliogenesis, cytokines production and as therapeutics target for managing MS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.